">
LG Chem will invest 2 trillion won ($1.6 billion) in its biopharmaceuticals business by the end of 2027, aiming to become a major player in the U.S. anticancer market.
LG Chem acquired Nasdaq-listed Aveo Pharmaceuticals for $566 million, the Korean chemical company said Tuesday.
Korea JoongAng Daily Sitemap